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Oxidative stress is a frequent condition in critically ill patients, especially if exposed to
extracorporeal circulation, and it is associated with worse outcomes and increased
mortality. The inflammation triggered by the contact of blood with a non-endogenous
surface, the use of high volumes of packed red blood cells and platelets transfusion, the
risk of hyperoxia and the impairment of antioxidation systems contribute to the increase
of reactive oxygen species and the imbalance of the redox system. This is responsible
for the increased production of superoxide anion, hydrogen peroxide, hydroxyl radicals,
and peroxynitrite resulting in increased lipid peroxidation, protein oxidation, and DNA
damage. The understanding of the pathophysiologic mechanisms leading to redox
imbalance would pave the way for the future development of preventive approaches.
This review provides an overview of the clinical impact of the oxidative stress during
neonatal extracorporeal support and concludes with a brief perspective on the current
antioxidant strategies, with the aim to focus on the potential oxidative stress-mediated
cell damage that has been implicated in both short and long-term outcomes.
Keywords: antioxidants, cardiopulmonary bypass, CRRT, ECMO, extracorporeal circulation, oxidative stress
Abbreviations: AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; ATP, adenosine triphosphate; CAT,
catalase; CPB, cardiopulmonary bypass; CRRT, Continuous Renal Replacement Therapies; Cys–S−, cysteine thiolate anion;
Cys-SO2H, cysteine sulfinic acid; Cys-SO3H, cysteine sulfonic acid; Cys–SOH, cysteine sulfenic acid; d-ROMs, reactive
oxygen metabolism and derivatives; ECC, extracorporeal circulation; ECMO, extracorporeal membrane oxygenation;
ELSO, extracorporeal life support organization; Fe2+, ferrous ions; Fe3+, ferric ions; FO, fluid overload; GPx, glutathione
peroxidases; Grx, glutaredoxin; GSH, glutathione; H2O2, hydrogen peroxide; hMSCs, hypoxia-preconditioned mesenchymal
stem cells; IFNβ, interferon β; IL, interleukin; MAS, meconium aspiration syndrome; MDA, malondialdehyde; MOF, multi-
organ failure; NAC, N-acetylcysteine; NADP+, nicotinamide adenine dinucleotide phosphate oxidated form; NADPH,
nicotinamide adenine dinucleotide phosphate reduced form; NEC, necrotizing enterocolitis; NO, Nitric oxide; NOS, nitric
oxide synthase; NOX, NADPH oxidase; O2, oxygen; O2−, superoxide anion; OH, hydroxyl radicals; ONO2−, peroxynitrite;
PCs, platelet concentrates; PFHb, plasma free hemoglobin; PPH, persistent pulmonary hypertension; PRBC, packed red blood
cells; PRx, peroxiredoxins; PUFA, polyunsaturated fatty acid; pVWF, plasmatic Von Willebrand factor; RBCs, red blood
cells; RDS, respiratory distress syndrome; RNS, reactive nitrogen species; ROS, reactive oxygen species; Se, selenium; SIRS,
systemic inflammatory response syndrome; SOD, superoxide dismutases; TAC, total antioxidant capacity; TF, tissue factor;
TNFα, tumor necrosis factor α; TR, thioredoxin reductase; Trx, thioredoxin; VA-ECMO, venous-arterial ECMO; VV-ECMO,
venous-venous ECMO.
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INTRODUCTION
Extracorporeal membrane oxygenation is life support for
reversible heart and/or lung failure refractory to standard
treatment, and it is used as bridge-to-recovery, bridge-to-
bridge, bridge-to-transplant, or bridge-to-decision (Brogan et al.,
2017). This technique was developed by the CPB technology,
and it is based on a partial/full bypass of the native cardiac
and/or pulmonary function. Neonatal respiratory ECMO was
introduced by Robert Bartlett during the 1970s for severe
hypoxemic respiratory failure secondary to MAS, PPH and RDS
(Bartlett et al., 1976). Despite the progress in neonatal care
following the introduction of new therapies and ventilatory
strategies, ECMO remains life-saving support for about 600–
800 neonates each year worldwide (Thiagarajan et al., 2017).
Across the world, from 1989 to 2017, about 27.238 newborns
needed an ECMO procedure for respiratory failure, 7.592 for
cardiac problems, 1.694 for extracorporeal cardiopulmonary
resuscitation; the overall survival rate is 83, 64, and 66%,
respectively (ELSO). Although the overall survival is high,
there are consistent differences in the incidence rates between
the diseases. Since 1979 the survival of ECMO patients with
congenital diaphragmatic hernia and sepsis is stable at around
51 and 48%, respectively. In contrast, PPH, RDS, and MAS
have a significantly higher survival of 73, 76, and 92%, each.
Furthermore, cardiomyopathy and myocarditis have better
survival (65 and 50%, respectively), compared to congenital
heart disease and cardiogenic shock (44 and 47%, respectively)
(ELSO). Nevertheless, the mortality of infants and children with
congenital heart disease has reduced in recent decades as a result
of the improvement of CPB techniques and myocardial protective
strategies (Gilboa et al., 2010; Cheng et al., 2014; Erikssen et al.,
2015). Nowadays, although the clinical management of ECMO
patients has remarkably progressed over the years, the rate of
complications (hemostatic disorders, brain damage, AKI, sepsis)
still have a high impact on patients’ outcome (ELSO).
Oxidative stress plays a critical role in the genesis of
tissue damage during an ECMO procedure, and newborns are
particularly prone to the toxic effects of free radicals, due to
the immaturity of their antioxidant systems resulting in lowered
detoxification capacity (Comporti et al., 2004; Castellheim et al.,
2005; Saugstad, 2005; Mishra et al., 2008; Signorini et al., 2008;
Afolayan et al., 2012, 2015; Annagür et al., 2015; Asci et al., 2015;
Mokra et al., 2015; Aras-López et al., 2016; Mikolka et al., 2016;
Mátyás and Zaharie, 2018; Moore et al., 2018; Perrone et al.,
2018). The inflammatory response following the introduction
of ECC generates a high amount of ROS contemporarily
reducing endogenous antioxidants (Descamps-Latscha, 2001;
Goodyear-Bruch and Pierce, 2002; Karu et al., 2010). Various
studies associated the exposure to extracorporeal circuits (CPB,
ECMO, and CRRT) with the increased oxidative stress that may
negatively impact on morbidity and mortality (McDonald et al.,
2014a). Redox imbalance is mainly induced in the early stage of
ECMO, especially after the CPB, while with prolonged exposure
(beyond 24 h) the TAC gradually restores (Wan et al., 1997;
Babior, 2000; Desborough, 2000; Clermont et al., 2002; Levy and
Tanaka, 2003; Kouchoukos et al., 2012; Chen Q. et al., 2014;
Zakkar et al., 2015a,b; Fudulu and Angelini, 2016; Petersen et al.,
2018). The modulation of oxidative stress would seem to be
of great clinical importance. Indeed, its manipulation through
the use of exogenous antioxidants, cardioplegia during CPB,
blood priming strategies, or miniaturization of the extracorporeal
circuit could mitigate the ROS production (Fudulu and Angelini,
2016). However, data are scant, especially for neonatal ECMO,
and are mainly related to pre-clinical evidence. This review
focuses on the mechanisms of oxidative stress during neonatal
ECMO, involved in the pathophysiology of both short and
long-term disorders as MOF, hemostatic derangements up to
neurodegenerative, cardiovascular and cancer disease in adults.
Lastly, a brief overview of currently available antioxidant
strategies is provided (Halliwell and Gutteridge, 2015).
REDOX BIOLOGY AND OXIDATIVE
STRESS
Energy is produced by mitochondrial metabolism through
glucose, amino acids and lipids combustion in the presence of
O2 (Semenza, 2009; Vento, 2014). Approximately 98% of O2 is
reduced to H2O by the conventional combustion process, while
only 2% of remaining O2 loses its electrons with the rear O2−
and ROS production (Maltepe and Saugstad, 2009; Vento, 2014).
The “old definition” of oxidative stress was referred to
conditions in which the balance between ROS production and
endogenous antioxidants break down resulting in tissue and
cellular injury through lipid peroxidation, protein oxidation, and
DNA damage (Schieber and Chandel, 2014). Currently, the “new
definition” is much more complex, referring to an imbalance
between oxidants and antioxidants in favor of the oxidants, that
cause an arrest of redox signaling and/or molecular damage
(Sies, 2018). More recently the term “reductive stress” has been
introduced, but its exact definition is still unclear (Gutteridge and
Halliwell, 2018). It would seem to be due to high levels of reduced
GSH and NADPH, unbalancing the redox system to the opposite
oxidative extreme, which has shown to play an essential role in
the pathogenesis of dilated cardiomyopathy in cases of lamin-
associated muscular dystrophy (Margaritelis et al., 2014; Dialynas
et al., 2015; Stevens et al., 2017; Bellezza et al., 2018).
The O2−, H2O2, OH•, and ONO2− are the most common
ROS, produced by aerobic metabolism (Schieber and Chandel,
2014). The intracellular O2− arises from the one-electron
reduction of molecular O2 that is primarily produced by the
oxidation of NADPH by NOX enzymes or by electron loss
from aerobic respiration in mitochondria (Lambeth, 2004; Brand,
2010; Sahoo et al., 2016). Superoxide anion is rapidly converted
by SOD into H2O2, and its storage is prevented by SODs, which
are mainly located in the cytosol and mitochondria. Conversely,
the increase in H2O2 triggers autophagy and cell death (Figure 1;
Fridovich, 1997; Chen Y. et al., 2009).
Cysteine residues within proteins are oxidized by H2O2 to
sulfenic form (Cys–SOH) and reduced to its basic thiolate
anion (Cys–S−) form by the disulfide reductases Trx and Grx
(Winterbourn and Hampton, 2008). The excess of H2O2 further
oxidizes thiolate anions to sulfinic (Cys-SO2H) or sulfonic
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FIGURE 1 | Redox Biology and Oxidative stress. The production of O-2 mainly occurs with the oxidation of NADPH into NADP+ in the presence of O2 and NOX, and
partly from an electron’s loss during the combustion of carbohydrates, amino acids, and lipids for the production of energy in mitochondria. Superoxide dismutases
(SOD) immediately transforms O−2 into H2O2 which is converted in OH
• in the presence of iron, if not degraded by antioxidant enzymes in H2O. Furthermore, the
excess of O−2 reacting with NO produces ONO
−
2 , which in turn participates in oxidative damage with OH
•. Contrarily, the standard production of O2− contributes to
the homeostasis of the redox signal. CAT, catalase; Cys–S−, cysteine thiolate anion; Cys-SO2H, cysteine sulfinic acid; Cys-SO3H, cysteine sulfonic acid; Cys–SOH,
cysteine sulfenic acid; Fe2+, ferrous ions; Fe3+, ferric ions; GPx, glutathione peroxidases; Grx, glutaredoxin; H2O2, hydrogen peroxide; NADP+, nicotinamide
adenine dinucleotide phosphate oxidated form; NADPH, nicotinamide adenine dinucleotide phosphate reduced form; NO, Nitric oxide; NOS, nitric oxide synthase;
NOX, NADPH oxidase; O2, oxygen; O2−, superoxide anion; OH, hydroxyl radicals; ONO2−, peroxynitrite; PRx, peroxiredoxins; SOD, superoxide dismutases; Trx,
thioredoxin.
(Cys-SO3H) classes. The sulfinic and sulfonic oxidation is
irreversible and could lead to permanent protein damage that is
prevented by PRx, GPx and CAT (Figures 1, 2; Winterbourn and
Hampton, 2008; Finkel, 2012). In contrast, the OH produced by
Fenton reaction in the presence of Fe2+ has a detrimental effect
on lipids, proteins, and DNA (Figure 1; Dizdaroglu and Jaruga,
2012).
Nitric oxide is one of the most important and ubiquitous
intracellular messengers that mediates several basic physiological
processes including neurotransmission, vasodilatation,
angiogenesis and host cell defense (MacMicking et al., 1997;
Egginton, 2009; Bogdan, 2015; Philippu, 2016; Kraehling and
Sessa, 2017). NO is synthesized from L-arginine by several forms
of NOS, and its reaction with O2− produces ONO2− which alters
mitochondrial function and causes apoptosis (Figure 1; Stuehr,
1999; Pacher et al., 2007; Radi, 2013).
Lipid Peroxidation
Lipid peroxidation, caused by increased ROS and RNS, is
linked to many acute and chronic diseases of adulthood
such as MOF, hemorrhagic and septic shock, ARDS, acute
lung injury, cardiovascular pathology requiring surgery, aging,
atherosclerosis, Parkinson, Alzheimer, diabetes mellitus, cataracts
and rheumatoid arthritis, and several diseases of the neonatal
period (Takeda et al., 1984; Hammond and Hess, 1985; Bertrand
et al., 1989; Richard et al., 1990; Quinlan et al., 1996; Carpenter
et al., 1998; Lamb et al., 1999; Motoyama et al., 2003;
Comporti et al., 2004; Quinlan et al., 2004; Fläring et al., 2005;
Laplace et al., 2005; Niki et al., 2005; Saugstad, 2005; Huet
et al., 2007; Signorini et al., 2008; Giustarini et al., 2009;
Briones and Touyz, 2010; Giacco and Brownlee, 2010; Khaper
et al., 2010; Romano et al., 2010; Barrera et al., 2018; Maiorino
et al., 2018; Mátyás and Zaharie, 2018; Moore et al., 2018;
Orban and Singer, 2018; Perrone et al., 2018; Romano et al.,
2018).
Lipid peroxidation is the oxidative decay of Puffs, which
involves the abstraction of hydrogen from a carbon molecule
with O2 insertion and consequent production of lipid peroxyl
radicals and hydroperoxides (Tappel, 1970; Yin et al., 2011; Al-
Dalaen and Al-Qtaitat, 2014). Hydroperoxides are very unstable
and easily decompose into MDAs and 4-hydroxy-2-nonenal,
while peroxidation of arachidonic acid produces isoprostanes
(Montuschi et al., 2004; Lakshminrusimha et al., 2006; Al-Dalaen
and Al-Qtaitat, 2014). The response of the cell membrane to lipid
peroxidation depends on the degree of peroxidation achieved.
If lipid peroxidation rate is low, the damage is repaired by
anti-oxidant defense systems. On the other hand, if the lipid
peroxidation rate is high, the tissue self-repairing capacity is lost,
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FIGURE 2 | Thioredoxin and Peroxiredoxin system. Reduced Trx-SH catalyzes the reduction of disulfide (s–s) bridges within oxidized cell proteins. This process
causes the oxidation of Trx-SH to Trx-disulfide which is subsequently reduced by TR at the expense of NADPH. The TR in its catalytic Trx reduction process uses Se
as a cofactor. Reduced PRx-SH promotes the separation of two H2O molecules from H2O2 through a “two-step mechanism.” The peroxidic cysteine sulfhydryl
group of a Prx subunit is oxidized to sulfenic acid (–SOH). Subsequently, sulfenic acid condenses with the reduced cysteine group present in the other subunit to
form a disulfide bond between the units. This two-step process releases two H2O molecules from H2O2 with the oxidation of PRx-SH to PRx-SOH to PRx-disulfide.
The oxidized PRx is in turn reduced by the Trx-SH. H2O2, hydrogen peroxide; NADP+, nicotinamide adenine dinucleotide phosphate oxidated form; NADPH,
nicotinamide adenine dinucleotide phosphate reduced form; PRx, peroxiredoxin; TR, thioredoxin reductase; Trx, thioredoxin.
and apoptosis or programmed cell death is induced (Chaudhary
et al., 2010; Ayala et al., 2014).
Oxidative Protein Damage
Protein oxidation damage does affect not only the cell membranes
but also the enzyme system because it is exclusively constituted
by proteins (Goodyear-Bruch and Pierce, 2002). The amino acid
fragmentation, the following generation of cross-links between
proteins and the oxidation of the body of the protein molecule
with loss of specific (contractile, enzymatic, and transport)
function is caused by ROS and RNS (Dalle-Donne et al., 2003a,b;
Giustarini et al., 2009). Protein Carbonyl groups (aldehydes
and ketones) are produced generally by the direct oxidation
of proline, arginine, lysine, and threonine residues, or by
oxidative cleavage of the protein backbone, and indirectly by lipid
peroxidation or reaction of reducing sugars or their oxidation
products (Dalle-Donne et al., 2003a, 2006). The damaged
proteins, in turn, contribute to many disorders and diseases
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(Dalle-Donne et al., 2003a). Oxidized or aldehyde-modified
proteins would be perceived as “foreign proteins” by the immune
system, with the production of self-antibodies in rheumatoid
arthritis, lupus, and scleroderma in adults (Mantle et al., 1999;
Dimon-Gadal et al., 2000; Renke et al., 2000; Dalle-Donne et al.,
2003a; Halliwell and Gutteridge, 2015). Moreover, always in
adults, the increase of oxidized proteins has been associated with
multiple diseases, like cancer, heart failure, pre-eclampsia, ARDS,
Parkinson, Alzheimer, and sepsis (Floor and Wetzel, 1998; Lenz
et al., 1999; Winterbourn et al., 2000; Butterfield et al., 2001;
Zusterzeel et al., 2001; Abu-Zidan et al., 2002; Castegna et al.,
2002). In the neonatal period, the oxidation of proteins plays a
key role in some diseases such as intraventricular hemorrhage,
retinopathy of prematurity, bronchopulmonary dysplasia, NEC
(Gladstone and Levine, 1994; Ramsay et al., 2001; Perrone et al.,
2009, 2010, 2014, 2018; Couroucli, 2017).
Oxidative DNA Damage
Oxidative DNA damage is generated by high OH• concentrations
(Cooke et al., 2003). ROS can damage both purines and
pyrimidines in DNA and in the free cell nucleotide pool and
generates 8-hydroxy-2′-deoxyguanosine that can be used as
a biomarker of the injury (Suliman et al., 2003; Bayr, 2005;
Li et al., 2014). Despite the damage, the cell continues the
replication process, replicating the damage and inducing the
new cells to apoptosis (Roos and Kaina, 2006). Furthermore,
oxidative DNA damage would be associated with other diseases
such as sepsis, carcinogenesis, neurodegenerative diseases,
cardiovascular diseases, and aging (Cooke et al., 2003; Niki et al.,
2005; Giustarini et al., 2009; Halliwell and Gutteridge, 2015;
Bahar et al., 2018; Gutteridge and Halliwell, 2018; Klaunig and
Je, 2018).
OXIDATIVE STRESS AND ECMO
To date, evidence of oxidative stress during ECMO are limited
and are mainly related to pre-clinical studies (Möller et al., 1993;
Trittenwein et al., 1999). Möller et al. (1993) observed a reduction
of the antioxidant capacity of SOD and GPx on a lamb ECMO
model, while increased lipid peroxidation was demonstrated on a
rabbit model of ECMO (Trittenwein et al., 1999). One study on
pediatric patients described two different oxidative stress patterns
during ECC; in non-survivors, lipid peroxidation augmented
during the first 96 h of ECMO whereas it reached a plateau after
24 h in the survivor’s group (Hirthler et al., 1992).
No data are currently available on critically ill neonates
undergoing respiratory ECMO. Despite this gap of knowledge,
previous evidence, mainly derived from studies on CPB and
critically ill patients, suggested that oxidative stress is a relevant
contributor to morbidity and mortality (Möller et al., 1993;
Trittenwein et al., 1999; Brix-Christensen et al., 2001, 2002;
Goodyear-Bruch and Pierce, 2002; Levy and Tanaka, 2003).
ECMO shares with both CPB and critical illness common
potential triggers for increased ROS generation and redox
unbalance: exposure to the extracorporeal circuit and related
SIRS, transfusion burden, hyperoxia, CRRT, hemolysis, and
sequestration of antioxidants into the ECMO circuit (McDonald
et al., 2014a). We describe hereafter the possible role of these
triggers in the pathogenesis of oxidative stress-related morbidity
during ECC.
ECMO and Inflammation
A SIRS-like syndrome is typically observed from the first hours
after starting an ECMO procedure, as a consequence of the blood
exposure to the exogenous surface of the extracorporeal device
(Davies and Hagen, 1997). Despite the use of biocompatible
equipment, the interaction between biological fluids and the
circuit activates both the coagulation cascade and the host
inflammatory response (Tayama et al., 2000; Palatianos et al.,
2003; Wiesenack et al., 2004; Thiara et al., 2010). The humoral
and cell-mediated immune response triggers the release of
pro-inflammatory cytokines (IL-1β, TNFα, and IFNβ), leading
to endothelial damage, disrupted microcirculation and multi-
organ dysfunction, in case of suboptimal compensatory anti-
inflammatory response (Hocker et al., 1991; Hirthler et al.,
1992; Depuydt et al., 1993; Plötz et al., 1993; Fortenberry et al.,
1996; Adrian et al., 1998; Graulich et al., 2002; Golej et al.,
2003; Mildner et al., 2005; Adib-Conquy and Cavaillon, 2009;
Mcilwain et al., 2010; He et al., 2014; Shi et al., 2014; Rungatscher
et al., 2015; Wang et al., 2015). The redox biology regulates
the homeostasis of innate and adaptive immune response
through ROS production. Many concurrent factors (hyperoxia,
blood products, sepsis, mechanical ventilation) contribute to the
increased ROS generation, thus promoting an overwhelming
release of pro-inflammatory cytokines (IL-1β, TNFα, and IFNβ)
and eventually the SIRS-like (Wiesenack et al., 2004; Cruz et al.,
2007; Chen and Nuñez, 2010; Iwasaki and Medzhitov, 2010;
Bulua et al., 2011; West et al., 2011; Mittal et al., 2014).
Furthermore, the intrinsic and extrinsic coagulation cascade
could be directly activated by the contact of blood with the
circuit surface or lesion of endothelium, or indirectly by ROS
mediation (Davie et al., 1991; Görlach, 2004, 2005; Herkert et al.,
2004; Mackman et al., 2007; Oliver, 2009; Fall et al., 2015).
The intrinsic coagulative pathway would be activated exclusively
during the respiratory ECMO with low thrombin generation;
while the release of high amount of TF and air-blood interface
would stimulate both the intrinsic and extrinsic way with high
thrombin generation during the CPB (Levy and Tanaka, 2003;
Oliver, 2009; Kraft et al., 2015). Indeed, TF binds to Factor
VII, converting it into Factor VIIa and activating the common
coagulation cascade (Davie et al., 1991; Levy and Tanaka, 2003;
Mackman et al., 2007; Oliver, 2009). The intrinsic pathway
is activated through the conversion of Factor XII into Factor
XIIa within 10 min from the beginning of the extracorporeal
procedure and is associated with an increase in Bradykinin,
Kallikrein, and activation of Factor IX (Wendel et al., 1999;
Millar et al., 2016). Bradykinin stimulates NO, TNFα, and IL-10
production, while Kallikrein directly activates neutrophils (Rodell
et al., 1995; Wachtfogel et al., 1995). Factor IXa induces the
activation of Factor X which in turn causes the conversion of
prothrombin into thrombin and fibrinogen in fibrin resulting in
thrombus formation (Millar et al., 2016). Thrombin stimulates
the endothelial production of P-selectin, E-selectin, and platelet
Frontiers in Physiology | www.frontiersin.org 5 December 2018 | Volume 9 | Article 1739
fphys-09-01739 November 30, 2018 Time: 17:55 # 6
Raffaeli et al. Neonatal ECMO and Oxidative Stress
activating factor, thus increasing the adherence and activation
of neutrophils and the expression of proinflammatory cytokines
(Prescott et al., 1984; Zimmerman et al., 1985; Kaplanski et al.,
1997; Levy and Tanaka, 2003). Additionally, thrombin stimulates
the production of ROS in endothelial and smooth muscle cells,
by stimulating NOX and by up-regulating the expression of NOX
sub-unit p22phox in a kinase-dependent manner (Görlach et al.,
2002; Djordjevic et al., 2005).
Oxidative stress induces platelets activation and aggregation
which, in turn, increases ROS production. Neutrophils
participate in the amplification of the immune response;
although multifocal, the activation of neutrophils occurs mainly
in the oxygenator; their margination in the artificial lung,
observed both in animal models and in newborns, contribute
to the deterioration of the artificial membrane during ECMO
(Plötz et al., 1993; Fortenberry et al., 1996; Kotani et al., 2000;
Brix-Christensen et al., 2002; Mcilwain et al., 2010; Rungatscher
et al., 2015).
In conclusion, the mechanism of ECMO-induced oxidative
stress is a multifactorial process, in which the interaction between
the immune response, the coagulation cascade, and endothelial
cells amplifies ROS generation (Figure 3).
ECMO and Blood Transfusion
Blood products have been associated with increased morbidity
and mortality in critically ill patients (Koch et al., 2008;
Wang et al., 2012; Ghirardello et al., 2017). Transfusion-related
oxidative stress increases with the volume, and the number of
PRBC transfused (Shohat et al., 1983; Silvers et al., 1998; Dani
et al., 2001; Collard et al., 2004). Rosa et al. (2011) observed that
blood transfusions were associated with a significant increase in
oxidative stress and a reduction of IL-6 concentration in critically
ill adults. The transfusion of aged PRBC was associated with
an increase of oxidative stress, as a consequence of the reduced
Se content in older PRBC. Se is an essential trace element,
which is incorporated into selenoproteins, some of which have
antioxidants function (i.e., GPx) (McDonald et al., 2014b). In
premature newborns, RBC transfusions were associated with
an increase of MDA, a lipid peroxidation product, both in
the bronchoalveolar lavage fluid and in urine (Wardle et al.,
2002). This data suggested that RBC transfusion could increase
pulmonary oxidative damage and worse prognosis (Collard et al.,
2005).
Extracorporeal membrane oxygenation, as well as CPB or
exchange transfusion, are procedures that expose patients to
a significant increase in PRBC transfusions and therefore to
oxidative stress (McCoy-Pardington et al., 1990; Luban, 1995;
Butch et al., 1996; Ang et al., 2009). Newborns receive an average
of 60 ml/kg/day of PRBC during an ECMO procedure (Stiller
et al., 2004). This high blood requirement depends on (1) priming
of the ECMO circuit with blood, to avoid acute hemodilution,
(2) frequent blood samples for coagulation tests, (3) hemolysis-
related anemia due to centrifugal pumps and, occasionally,
(4) spontaneous bleeding from cannulation sites and surgical
FIGURE 3 | Main determinants of ECMO-induced oxidative stress. Graphical representation of the interaction between the coagulation cascade, the immune
response, and the endothelium in the multifactorial amplification process of the ECMO-related redox unbalance. ICAM, intercellular adhesion molecule. VCAM,
vascular cell adhesion molecule.
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wounds. According to the ELSO registry, these latter events
represents about 19% of all hemorrhagic complications during
neonatal respiratory ECMO, impacting on survival (ELSO).
Overall, the mortality rate is increased among neonates exposed
to large volumes of PRBC transfusions (Smith et al., 2013; Fiser
et al., 2014; Ghirardello et al., 2017). Dos Santos et al. observed
a 27.8% mortality in critically ill infants exposed to transfusions
during the hospital stay, with an increased relative risk of death
of 1.49 in those infants who received at least one transfusion
compared to controls (Dos Santos et al., 2011). In a cohort of
extremely low birth weight infants, the incidence of mortality
was 24% in patients transfused compared to 8.5% in the control
group (Ghirardello et al., 2017). Similarly, Smith and co-authors
observed a 24% increase in the odds of hospital death associated
with every 10 ml/kg/day of PRBC transfusion in patients during
respiratory ECMO (Smith et al., 2013).
In addition to PRBC, newborns on ECMO require
approximately 25 ml/kg/day of PCs (Stiller et al., 2004).
Platelet count is reduced by 40–50% during ECMO, partly due to
the activation of the coagulation cascade (Nawab and Williams,
2017). Moreover, PCs are a source of ROS, especially O−2 , which
modulate platelet activation and aggregation (Krötz et al., 2002;
Begonja et al., 2005). The increase in ROS, whose impact on the
patient’s oxidation state is still unknown, is mainly related to the
storage process (Sonego et al., 2017).
ECMO and Hemolysis
ECMO-related hemolysis is a common phenomenon among
pediatric patients and represents an independent predictor of
mortality (Omar et al., 2015; Dalton et al., 2018). It consists
of the RBCs lysis with following release of hemoglobin into
the plasma (Rother et al., 2005). The shear stress is the
main causative mechanism for hemolysis during mechanical
support, and some risk factors have been identified, such as
the negative inlet pressure, pump speed, pump and oxygenator
type, cavitation and priming solution (Steinhorn et al., 1989; Lou
et al., 2014; Rother et al., 2005). In addition, oxidative stress
is a determinant of hemolysis (Boyle et al., 1997; Walski et al.,
2018). Lipid peroxidation and protein damage of cell membranes
from ROS cause enzymatic inactivation, depolarization of the
cell membrane and a change in its permeability, resulting in
cell lysis (Matés et al., 1999; Kirkham and Rahman, 2006).
The mechanical and oxidative stress during ECMO leads to
the release of the PFHb, which is cleared by hemoglobin
scavengers (Dalton et al., 2018). However, in case of severe
hemolysis, the hemoglobin-scavenging mechanisms become
saturated, resulting in hemoglobinemia and hemoglobinuria
(Rother et al., 2005). The PFHb may exert either a direct toxic
effect (i.e., renal damage) or may cause endothelial dysfunction,
by binding NO. The NO consumption leads to increased systemic
and pulmonary resistance, platelet activation and aggregation,
endothelial adhesion, fibrin deposition and thrombin formation
(Rother et al., 2005).
Moreover, the shear stress induces procoagulant
conformational changes of the pVWF, which interacts with
circulating platelets enhancing their adhesion and aggregation
properties (Cruz et al., 2018).
Furthermore, high levels of PFHb inhibit the cleavage of
pVWF by ADAMTS-13, contributing to increased clotting
within the mechanical devices (Da et al., 2015). Eventually,
hyperbilirubinemia and iron release constitute additional drivers
of the hemolysis-induced morbidity and mortality (Davis
et al., 1999; Kaplan et al., 2014). Besides hemolysis, the
mechanical stress may hesitate into sublethal RBCs damage,
leading to increased fragility and decreased deformability of
RBCs (Kameneva et al., 1999). Their consequent failure to
enter small capillaries causes end-organ dysfunction, through
the impairment of tissue oxygenation and microcirculation
(Watanabe et al., 2007). Based on the concepts mentioned
above, ECMO providers should monitor the hemolysis, as it
is strictly associated with increased mortality and morbidity
(kidney injury, vascular impairment, need for PRBC and PCs
transfusion, thrombosis).
Moreover, efforts should focus on the technological progress,
because of specific components of the circuit act as main
drivers of the ECMO-induced hemolysis, such as the oxygenator
(Williams et al., 2015). The use of smaller pediatric oxygenators
was associated with greater shear stress and, hence, increased
hemolysis, when compared to larger adult oxygenators (Williams
et al., 2015). Although the relative contribution of each
circuit component on the hemolysis and related oxidative
stress is unknown, the use of a centrifugal pump and small
size connectors should be considered as potential sites of
increased hemolysis (Lou et al., 2014; Williams et al., 2015).
Furthermore, the use of red-to-infrared radiation (R/NIR) to
stabilize erythrocyte membranes with increased resistance to
oxidative stress seems promising (Itoh et al., 2000; Komorowska
et al., 2001; Chludzin´ska et al., 2005; Walski et al., 2015, 2018).
Technology advances should target the development of new,
more bio-compatible, circuit-blood interfaces in order to reduce
hemolysis and oxidative stress.
ECMO and Hyperoxia
The antioxidant capacity of tissues is overtaken with O2−
production during hyperoxia. Oxygen toxicity in the perinatal
period is well established, and many efforts have been made to
define safety targets during neonatal resuscitation and care (Tin
and Gupta, 2007; Auten and Davis, 2009; Finer and Leone, 2009;
Askie et al., 2011; Saugstad et al., 2012; Vento et al., 2012; Schmidt
et al., 2013; Saugstad and Aune, 2014; Manja et al., 2015).
Nevertheless, hyperoxia remains a significant driver for radical
O2 species generation, especially during ECC (Cashen et al.,
2018). Hyperoxia is frequent during cardiac surgery in CPB and
seems to play a key role in the development of oxidative stress
as a consequence of post-ischemic reperfusion (Cavarocchi et al.,
1986; Börgermann et al., 2007). The clamp of the aorta induces
heart and lung ischemia while declamping generates reperfusion,
and either action produces an inflammatory response. On-pump
cardiac surgery is associated with increased oxidative stress if
compared to off-pump surgery (Matata et al., 2000; Cavalca et al.,
2006). The post-ischemic reperfusion, rather than hyperoxia per
se, seems to play a role; there is evidence from pediatric cardiac
surgery that isolated hyperoxia does not increase oxidative stress
and inflammation if compared with normoxia (Hövels-Gürich
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et al., 2002; Caputo et al., 2005, 2009). Although ECMO does not
directly cause ischemia/reperfusion, patients requiring ECMO
experience prolonged periods of pre-ECMO hypoxia causing
an increase in oxidative stress (Crimi et al., 2006; Hayes et al.,
2013; Chen Q. et al., 2014). ROS generation following hyperoxia
is significantly exaggerated when hyperoxia is subsequent a
period of hypoxia, due to the dysfunction of the post-ischemic
mitochondrial electron transport chain (Neumar, 2011). Sznycer-
Taub et al. (2016) identified hyperoxia within 48 h of ECMO
following cardiac surgery as an independent risk factor for
mortality at 30 days post-operatively, while Trittenwein et al.
(1999) observed how VV-ECMO more than VA-ECMO would
increase pulmonary lipid peroxidation following endotoxemia-
induced hypoxia. Lipid peroxidation of the lung is a known
consequence of sepsis and inflammation, but it has also been
described as a consequence of tissue reperfusion (Demling et al.,
1991; Horton and Walker, 1993; Christie et al., 1994; Chow
et al., 2003). In the study by Trittenwein et al. (1999) hyperoxic
reperfusion of the hypoxic lung following VV-ECMO, caused
a significant increase of plasma MDA as an index of lipid
peroxidation, higher than that observed in VA-ECMO where the
hyperoxic blood supply to the lung is less.
More recently, similar results have been observed by Cashen
et al. (2018) that showed higher in-hospital mortality among
hyperoxic patients submitted to ECMO compared to normoxics,
ascribing the high mortality to the effects of ROS on poor cardiac
output rather than the SIRS-like syndrome, hemostatic activation
and MOF.
ECMO and Continuous Renal
Replacement Therapies
Oxidative stress is a common condition in kidney diseases
(Witko-Sarsat et al., 1996; Hasselwander and Young, 1998); it
is induced by renal pathology itself, reduced antioxidant intake
associated with malnutrition, CRRT with the loss of antioxidant
molecules during filtration and the contact of blood with CRRT
circuit (Wolf et al., 1951; Hasselwander and Young, 1998;
Cano, 2001; Sosa et al., 2006; Varan et al., 2010; Libetta et al.,
2011; Coombes and Fassett, 2012; Ozbek, 2012). The SIRS-like
syndrome, which typically occurs in the early hours of ECMO,
is associated with hypotension, oligo-anuria, decreased lung
compliance, pulmonary edema, increased plasma concentrations
of pro-inflammatory cytokines and neutrophils’ activation
(Hocker et al., 1991; Davies and Hagen, 1997). AKI and FO
complicate neonatal ECMO runs in more than half of cases, with
a negative impact on survival rates (Heiss et al., 1987; Weber
et al., 1990; Swaniker et al., 2000; Gadepalli et al., 2011; Zwiers
et al., 2013). Therefore, hemofiltration and hemodialysis have
become a standard of care in the management of AKI during
ECMO (Heiss et al., 1987; Meyer et al., 2001; Paden et al., 2011;
Chen H. et al., 2014). During CRRT, inflammation is activated
by an increase of ROS and inflammatory cytokines (TNFα, IL-1,
and IL-6) (Tarakçıog˘lu et al., 2003; Borazan et al., 2004) and
a reduction of antioxidant proteins as hydrosoluble vitamin
C and uric acids (Hegbrant and Hultkvist, 1999; Yang et al.,
2006; Libetta et al., 2011). The use of biocompatible filtration
systems by using vitamin E-coated filters reduces the oxidative
stress linked to the contact of blood with exogenous materials
(Yang et al., 2014). Selewski et al. (2012) suggested an early
filtration treatment to anticipate FO, and reduce mortality rate.
As reported by ELSO registry, about 33% of neonatal respiratory
ECMO and 38% of cardiac ECMO require renal replacement
therapy (ELSO). As a result of the combination of two ECC
systems, the hemolysis-related oxidative stress would increase
(Chen H. et al., 2014). The in-line use of CRRT would limit the
ECMO-related inflammation by reducing the concentrations of
TNFα, IL-1β, IL-6, and IL-8 (Jialiang et al., 2014).
ECMO Post-cardiopulmonary Bypass
Adult patients with cardiovascular diseases and neonatal patients
with congenital cyanotic heart diseases have an increased level
of oxidative stress, even before heart surgery, if compared to the
healthy population (Ercan et al., 2009; Giustarini et al., 2009; Karu
et al., 2010; Small et al., 2012).
Moreover, cardiac surgery is always associated with both
systemic inflammation and a variable degree of oxidative stress,
which might contribute to post-operative complications, failure
of single and multiple organs and mortality (Kim et al., 2008;
Billings et al., 2011; Antoniades et al., 2012; Plicner et al., 2014;
Wu et al., 2015). Plicner et al. (2014) observed that the increase
of asymmetric dimethylarginine and 8-iso-prostaglandin F2α was
associated with an unfavorable outcome of patients undergoing
coronary artery bypass grafting. Similarly, Antoniades et al.
(2012) has shown how the increase of O2− and ONO2−
concentration was closely related to atrial fibrillation, need for
inotropic drugs and lengthening of hospital stay during post-
cardiac surgery.
The main cause of oxidative stress during cardiac surgery is
the exposure to the foreign surface of the extracorporeal circuit,
hypothermia, and circulatory arrest associated with systemic
inflammation, ischemia-reperfusion injury, altered hemostatic
status (Prasad et al., 1992; Edmunds, 1998; Clermont et al., 2002;
Levy and Tanaka, 2003; Ulus et al., 2003; Gessler et al., 2004;
Karu et al., 2010). Approximately 3–5% of patients undergoing
congenital cardiac surgery require post-CPB extracorporeal
support, due to the weaning failure following myocardial
dysfunction, low cardiac output state, cardiac or respiratory
arrest, pulmonary hypertension, or shunt occlusion (Aharon
et al., 2001; Salvin et al., 2008; Mascio et al., 2014). The long
duration of ECMO post-CPB might impair the organ function,
thus predisposing to an increased risk of complications (i.e.,
sepsis) and mortality (Duncan et al., 1999; Chaturvedi et al., 2004;
Salvin et al., 2008; Kumar et al., 2010; Rood et al., 2011; ELSO,
2018).
CLINICAL RELEVANCE OF OXIDATIVE
STRESS DURING NEONATAL ECMO
The role of continuing oxidative stress has been established in
the long term, in a variety of chronic diseases, such as diabetes
mellitus, atherosclerosis and neurodegenerative illness (Haidara
et al., 2006). Currently, the interest is moving toward the effects
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of the redox unbalance in the acute illness (Bar-Or et al., 2015).
Here, we summarize the available evidence in relation to the role
of the oxidative stress in critical conditions, which often occur
during ECMO (Figure 4).
Sepsis and Multi-Organ Failure
A wealth of studies has shown that the normal redox balance is
altered in septic shock and multiple organ failure, due to both
an increase in O−2 derived free radicals and a decrease in the
plasma antioxidant potential (Ogilvie et al., 1991; Goode et al.,
1995). Adult septic patients have higher plasma CAT and SOD if
compared to healthy controls (Warner et al., 1995). Moreover,
non-survivors of sepsis have shown higher levels of SOD and
a reduced plasmatic antioxidant status, which was associated
with unfavorable outcomes (Cowley et al., 1996; Guerreiro et al.,
2010). The sepsis-related MOF, which remains the major cause
of death in intensive care units, is associated with oxidative
stress and mitochondrial dysfunction (Brealey et al., 2002; Galley,
2011). Two antioxidants targeting the protection of mitochondria
(MitoQ and MitoVitE) through the reduction of oxidative stress
have been beneficial in a rat model of acute sepsis (Lowes et al.,
2013). Other potential oxidative-induced mechanisms for MOF
development have been proposed, as a result of the anti-oxidant
impairment secondary to GSH and Se depletion, suggesting
a positive effect of Se supplementation (Brealey et al., 2002;
Manzanares et al., 2012; Broman et al., 2018).
Hemostatic Derangement and
Anticoagulation Management
Maintaining the hemostatic homeostasis during ECMO is
extremely challenging and, despite technical advances, bleeding
and thrombosis remain serious complications (Murphy
et al., 2015). The hemostatic perturbation during ECMO is a
multifactorial process, and the redox imbalance is one of the
main contributing factors. Besides the dilutional coagulopathy,
which depends on priming compositions and affects both
clotting factors and platelets, the shear stress has a key role as
it induces platelet dysfunction, fibrinolysis activation, acquired
von Willebrand syndrome and intravascular hemolysis (Görlach
et al., 2002; Görlach, 2004, 2005; Fall et al., 2015). As previously
mentioned, the oxidative stress is strictly associated with the
shear stress, resulting in endothelial activation (see section
“ECMO and Inflammation”) and enhanced hemolysis (see
section “ECMO and Hemolysis”) (Görlach et al., 2002; Görlach,
2004, 2005; Herkert et al., 2004; Djordjevic et al., 2005; Millar
et al., 2016).
Moreover, the exposure to the exogenous circuits triggers a
SIRS-like syndrome, which is associated with the ROS generation,
the release of pro-inflammatory cytokines, the activation of
the intrinsic coagulation pathway with a potential procoagulant
effect (Millar et al., 2016). The clot formation triggers the
consumption of coagulation factors and platelets, thus increasing
the risk of disseminated intravascular coagulopathy and bleeding
(Millar et al., 2016). The anticoagulation management should
be modulated, by taking into account the drivers of hemostatic
unbalance mentioned above.
Biomarkers of the Redox State
Based on the relevant clinical implication of the redox unbalance
during ECMO, the identification of diagnostic markers would
help in the detection, monitoring, and follow-up of the redox
potential in ECMO neonates. However, the profile of biomarkers
of both oxidative stress and antioxidant defenses during neonatal
ECMO has not been characterized yet. Evidence can be derived
from previous pre-clinical and clinical studies, which evaluate
the pro-oxidative potential during and after the exposure to
an extracorporeal circuit (i.e., CRRT, CPB) (Takouli et al.,
2010; McDonald et al., 2012). As most of the research has
been performed on the adult population, the evaluation of the
redox status in neonatal systemic diseases (i.e., septic shock)
may provide further insights into the age-related antioxidant
deficiency (Batra et al., 2000). Among potential pro-oxidant
FIGURE 4 | Clinical relevance of ECMO-induced oxidative stress. AF, atrial fibrillation; ARDS, acute respiratory distress syndrome; ECC, extracorporeal circuit; IBD,
intestinal bowel disease; MOF, multi-organ failure; SIRS, systemic inflammatory response syndrome.
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biomarkers, the d-ROMs have been evaluated in a dialyzer, while
the MDA has been applied in a porcine ECMO model (Takouli
et al., 2010; Chen Q. et al., 2014).
Additionally, as nitro-oxidative stress is involved in a large
variety of pathological mechanisms, the biomarkers validated for
the detection of nitrosation and nitration would be of interest
(Cipak Gasparovic et al., 2017). However, their application in
the extra-corporeal setting is still lacking. The anti-oxidant
response may be evaluated through the detection of the TAC,
SOD, and GSx activity (Takouli et al., 2010; McDonald et al.,
2012). Moreover, the reduction of key trace elements, such
as Se, copper, and zinc might suggest a reduced anti-oxidant
activity (McDonald et al., 2012). In clinical practice, the oxidative
stress may be indirectly presumed through the monitoring of
inflammatory markers, such as the increased levels of IL-6 and
IL-8 or by evaluating the hemolysis with the PFHb levels (Rother
et al., 2005; Takouli et al., 2010; Cruz et al., 2018).
STRATEGIES TO REDUCE OXIDATIVE
STRESS: UPDATE ON ANTIOXIDANTS
The ROS production is regulated by intra and extracellular
antioxidant systems, which are impaired during the perinatal
period and critical illness (Manzanares et al., 2012; McDonald
et al., 2012). ECMO further complicates the issue, by adding
specific sources for redox state unbalance (Manzanares et al.,
2012; McDonald et al., 2012, 2014a; Jialiang et al., 2014; Millar
et al., 2016; Bocca et al., 2017). The antioxidant system of the
newborns is immature with both a reduction of antioxidant
enzymes (SOD, CAT, and GPx) and non-enzymatic antioxidants
(vitamin E, β-carotene, melatonin, ceruloplasmin, transferrin,
coenzyme Q) while ascorbic acid and bilirubin are present only
for a short period after birth (Gopinathan et al., 1994; Gitto
et al., 2009; Bocca et al., 2017). Free iron levels are significantly
higher than in adults, causing an increased Fenton reaction,
which in turn stimulates the production of OH• (Saugstad,
2005). Furthermore both the SIRS-like and the sequestration
into the ECMO/hemofilter circuit reduce the level of trace
elements (copper, manganese, zinc, iron, Se as cofactors for
SOD, GPx, and CAT function) and non-enzymatic antioxidants
(albumin, uric acid, vitamins C and E) (Cano, 2001; Yamamoto
et al., 2003; Yamawaki and Berk, 2006; Berndt et al., 2007;
Tonelli et al., 2009; Hoffmann et al., 2011; Visser et al., 2011;
Manzanares et al., 2012; Wołonciej et al., 2016; Ciapetti et al.,
2018).
Based on the paucity of data regarding patients in ECMO
both neonatal and adult, we will illustrate previous data regarding
the use of anti-oxidants in critically ill adult patients undergoing
surgery, CRRT or CPB. Moreover, taking into account the
peculiarity of the perinatal period, we will mention some data
on anti-oxidant strategies studied in neonatal conditions where
oxidative stress is one of the pathogenic mechanisms, such as
sepsis or NEC (Ozdemir et al., 2012; Poggi and Dani, 2018)
(Supplementary Table S1). Among others, vitamin A, vitamin
E, vitamin C, SOD, and NAC have been studied to reduce tissue
damage mediated by oxidative stress with contrasting results
(Tyson et al., 1999; Suresh et al., 2001; Wardle et al., 2001; Brion
et al., 2003; Darlow et al., 2016).
Antioxidants have two main mechanisms of action: the
prevention, inactivating the free radical present in the systems
and the scavenging of the active radical, suppressing the chain
initiation or breaking the chain propagation. They may exert their
effect by many actions including electron donation, hydrogen
donor, metal ion chelation, co-antioxidants, radical scavenger,
peroxide decomposer, singlet oxygen quencher, enzyme inhibitor
or by gene expression regulation (Lobo et al., 2010).
Selenoproteins contribute to the function of many enzymes
among which GSx, TRs, and methionine sulfoxide reductase and
seem to protect the cardiovascular system against oxidative stress
(Rotruck et al., 1973; Kim and Gladyshev, 2004; Hoffmann and
Berry, 2005; Berndt et al., 2007; Hoffmann et al., 2011). Based on
the reduction of Se levels in critically ill patients or after cardiac
surgery, Se supplementation has been investigated in this contexts
with contradictory results (Manzanares et al., 2012; Stoppe et al.,
2013; Broman et al., 2018). To date, there are no data to support
its extended use (Allingstrup and Afshari, 2015; Manzanares et al.,
2016). Although not conclusive, neonatal supplementation with
oral or parenteral Se in the first weeks of life to preterm infants
led to a reduction in the proportion of infants having one or more
episodes of sepsis (Darlow and Austin, 2003). The administration
of pre and post-operative vitamin C in cardiac surgical adults
has led to a reduction of post-operative atrial fibrillation, which
seems to be associated with increased atrial oxidative stress and
ONO2− formation (Carnes et al., 2001).
Moreover, supplementation with ascorbic acid caused a
reduction of plasma levels of oxidative stress during hemodialysis
and restoration of endothelial function in critically ill patients
(Eiselt et al., 2001; Wilson, 2009).
Similarly, vitamin E-coated dialysis membranes used in adult
patients on hemodialysis led to a decrease in reactive oxygen
metabolites and derivatives, an increase of TAC and superoxide
dismutase (Takouli et al., 2010). In addition, a decrease in
post-operative atrial fibrillation has been documented after the
supplementation of pre and post-operative NAC in surgical adult
patients (Ozaydin et al., 2008). Ozdemir et al. (2012) have shown
a beneficial effect of NAC in a murine NEC model in terms
of reduced levels of oxidative stress (MDA) and inflammation
(TNFα), with increased antioxidant activity of the SOD. Also
concerning the supplementation of glutamine, data are not
conclusive. Indeed, previous studies showed that infusion of
glutamine during and for 3 days after cardio-surgery in adult
patients led to an increase of glutamine blood levels and GSH
activity without clinical improvement (Engel et al., 2009). Enteral
glutamine either alone or in combination with arginine has been
tested in healthy newborn rats showing a reduction of oxidative
stress. These results may suggest a potential benefit of glutamine
and arginine supplementation in the prevention of NEC in
premature neonates with insufficient oxidative resistance (Kul
et al., 2009). The evidence is building on the neonatal use of the
ROS scavenger melatonin. Its supplementation in newborns with
sepsis within the first 12 h after diagnosis has led to a reduction of
lipid peroxidation products (MDA) and improvement of clinical
outcomes (Gitto et al., 2001). The post-operative administration
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of melatonin reduced the proinflammatory cytokines and NO
levels in newborns undergoing surgery (Gitto et al., 2004).
Moreover, a reduction of late-onset sepsis risk ratio has been
shown in newborn supplemented with lactoferrin and a reduction
of the risk of antibiotic treatment failure in septic newborns
exposed to zinc (Bhatnagar et al., 2012; Pammi and Suresh,
2017). Additional promising agents are the apocynin, an NOX
inhibitor applied in the animal model of stroke and brain injury
induced by ischemia-riperfusion, and the α-lipoic acid, a GSH-
mediated antioxidant used in adults undergoing surgery during
ECC (Packer et al., 1997; Kahles et al., 2007; Lambeth et al.,
2008; Aly et al., 2009; Chen H. et al., 2009; Choi et al., 2010;
Xia et al., 2010; Simonyi et al., 2012; Uyar et al., 2013). Novel
antioxidant molecules, such as the ROS scavenger edaravone,
showed promising results. In a pre-clinical model of neonatal
sepsis the administration of edaravone 30 min after the injury has
led to both a biochemical and clinical improvement (Kato et al.,
2009). Other agents like hyperbaric oxygen and medical ozone
have been suggested to reduce oxidative stress by enhancing the
antioxidant system. The technique based on the use of O2/ozone
mix was previously applied in CRRT with promising results,
even if its mechanism of action remains still unveiled (Bocci
et al., 1999, 2001; Bocci and Paolo, 2004; Di Paolo et al., 2005).
Data on the use of ozone in ECMO are lacking and might
be a future area of interest. Lastly, it is worth mentioning the
potential role of hMSCs in ischemia/reperfusion-induced lung
injury, by acting through anti-oxidant, anti-inflammatory, and
anti-apoptotic defense pathways (Ortiz et al., 2003; Gupta et al.,
2007; Xu et al., 2007; Lee et al., 2009; Gotts and Matthay, 2011;
Liu et al., 2017).
CONCLUSIONS AND FUTURE
PERSPECTIVES
The imbalance of the redox system induced by the ECC is a field
of active research, but many aspects of neonatal ECMO and its
potential harm remain unsolved. Key points for both caregivers
and researchers of the perinatal area addressing the burden of
ECMO should include the following:
• Improve our knowledge of the mechanisms of oxidative
stress during neonatal ECMO, both in pre-clinical and
clinical settings, with a focus on the biochemical and
cellular mechanism that could contribute to multi-organ
damage.
• Define biomarkers for oxidative stress that could be a
potential target for pharmacological approaches.
• Support technological research to improve ECMO circuit
miniaturization and biocompatibility.
• Prevent the redox state unbalance during ECMO, through
the promotion of rational use of blood products, the
maintenance of well-defined O2 targets, the prevention
of hemolysis and AKI, the timely resort to in-line renal
replacement therapy, the simplification of ECMO circuit
lines.
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